Related Experiment Video

Updated: Jun 14, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Mig-6 controls EGFR trafficking and suppresses gliomagenesis

Haoqiang Ying1, Hongwu Zheng, Kenneth Scott

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 31, 2010
PubMed

Insights

Loss of the Mig-6 gene suppresses tumors by regulating epidermal growth factor receptor (EGFR) degradation in brain cancer. This finding reveals a new mechanism for controlling cancer cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain cancer driven by abnormal signaling, particularly from the epidermal growth factor receptor (EGFR).
  • The regulation of EGFR signaling through endocytosis and lysosomal degradation is crucial but not fully understood in cancer.

Purpose of the Study:

  • To investigate the role of the Mig-6 gene, located in a frequently deleted region of GBM, in regulating EGFR signaling and tumor suppression.
  • To elucidate the molecular mechanism by which Mig-6 controls EGFR trafficking and degradation.

Main Methods:

  • High-resolution genomic profiling of GBM to identify genetic alterations.
  • Functional assays to assess the impact of Mig-6 on GBM cell malignancy and EGFR signaling.
  • Co-immunoprecipitation and microscopy to study protein interactions and cellular localization.

Main Results:

  • A recurrent 1p36 deletion in GBM frequently eliminates the Mig-6 gene, a putative tumor suppressor.
  • Mig-6 suppresses GBM cell malignancy and dampens EGFR signaling by promoting EGFR's degradation via the lysosome.
  • Mig-6 binds to the SNARE protein STX8, facilitating the trafficking of internalized EGFR to late endosomes and subsequent lysosomal degradation.

Conclusions:

  • Mig-6 acts as a tumor suppressor in GBM by linking EGFR to the lysosomal degradation pathway through interaction with STX8.
  • Loss of Mig-6 in GBM sustains oncogenic EGFR signaling, highlighting a novel mechanism of receptor trafficking regulation in cancer.

More Related Videos

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice08:11

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

Published on: September 26, 2011

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...